PTPI (petrospharma.com) Bozor qiymatining balans qiymatiga nisbati

Petros Pharmaceuticals Inc (PTPI) kompaniyasining rasmiy ramzlari

GURU.Markets grafigidagi bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati tarixi Petros Pharmaceuticals (PTPI) -0.01 yangi darajaga yetayotganini ko'rsatmoqda. Ushbu narx harakati global inqirozlardan mustaqil qolgan sektorni himoya xarakterini aks ettiradi. O'sish Stendra ni OTC bozoriga chiqarish rejalari va telemeditsina rivojlanishi bilan qo'llab-quvvatlanmoqda, garchi boshqaruv shaffofligining pastligi va cheklangan tijoratlashtirish tajribasi aksiyadorlar uchun ma'lum risklarni yuzaga keltirsa-da.

PTPI Petros Pharma: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.06.2025 oraligʻida

Petros Pharmaceuticals Inc (PTPI) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Petros Pharmaceuticals|PTPI - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Petros|PTPI - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Petros Pharmaceuticals|PTPI - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati petrospharma.com|PTPI - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Petros Pharmaceuticals|PTPI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Petros|PTPI - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Petros|PTPI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Petros Pharmaceuticals
Kompaniyaning dastlabki tahlili:Petros Pharmaceuticals - PTPI
Petros original mahsuloti

Petros Pharmaceuticals (PTPI) kompaniyasining bozor shoklariga chidamliligini baholashda, uning sof aktivlar qiymatini tahlil qilish muhimdir. Biznes daromadlari erkaklar salomatligi uchun urologik dori vositalarining sotuvi orqali shakllantiriladi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati grafigi investorlarning har bir dollar kapital uchun to'laydigan premiumini aks ettiradi. Yuqori koeffitsient optimizmni anglatadi, ammo xavfsizlik zaxirasini kamaytiradi, bu esa tendentsiya teskariga o'zgarsa, korreksiya xavfini belgilaydi.

Asosiy raqobatchilar

Haleon plc - Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|MindWalk Holdings Inc. (HYFT) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ABVC BioPharma Inc. ABVC|CPIX (Cumberland Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Quantum BioPharma Corp (QNTM) - Bozor qiymatining balans qiymatiga koeffitsiyenti|FGEN - Kapitallashuvning sof aktivlarga nisbati|TELO (telomirpharma.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|RANI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SNYR|Rallybio Corporation - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti LEXX (lexariabioscience.com)|Bozor qiymatining balans qiymatiga nisbati PULM|PTHL - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Aptorum (APM)|LYRA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Impact BioMedical (IBO)|TNF Pharmaceuticals, Inc. (TNFA) - Sof aktivlarga nisbatan bozor kapitallashuvi|YCBD - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati painreform.com|Bozor kapitallashuvining balans qiymatiga nisbati CYTO|Bozor kapitallashuvining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals Inc)|Bozor qiymatining balans qiymatiga nisbati Optinose|Pieris Pharma - Balans qiymatiga nisbatan bozor qiymati|PROC: Bozor qiymatining balans qiymatiga nisbati|QLI - Kapitallashuvning sof aktivlarga nisbati|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Bozor kapitallashuvining balans qiymatiga nisbati